Grants per year
Personal profile
Training Experience
| 2012 | Postdoctoral Fellowship, University of Michigan |
Research Interests
I have been working on prostate cancer and epigenetics for over 15 years and published over 30 peer-reviewed publications. My major contributions to the field of prostate cancer and other cancer research include: (1) identification of PcG protein histone methyltransferase EZH2 as a biomarker for aggressive breast and prostate cancer; (2) characterization of EZH2 as an oncogene by repressing multiple tumor suppressors in breast and prostate cancer; (3) discovery of genomic loss of miR-101 in breast and prostate cancer and the upregulation of EZH2 by miR-101 in cancer; and (4) the coordinated regulation between Polycomb Repressive Complexes 1 and 2 in breast and prostate cancer progression. My work has demonstrated EZH2 and BMI1 as valuable therapeutic targets in cancer, and several pharmaceutical companies are developing EZH2- or BMI1- specific inhibitors for cancer therapy.
Education/Academic qualification
PhD, University of Michigan
… → 2008
MS, Peking University
… → 2001
Fingerprint Dive into the research topics where Qi Cao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 14 Similar Profiles
Prostatic Neoplasms
Medicine & Life Sciences
Gene Fusion
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Polycomb-Group Proteins
Medicine & Life Sciences
Androgen Receptors
Medicine & Life Sciences
Long Noncoding RNA
Medicine & Life Sciences
MicroRNAs
Medicine & Life Sciences
Sarcosine
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2018 2022
The role of A-to-I RNA editing in advanced prostate cancer
U.S. Army Medical Research and Materiel Command
9/30/19 → 9/29/22
Project: Research project
RNA Editing
Prostatic Neoplasms
RNA
Proteins
immune RNA
The inhibitory network between EZH2 and PARP1 in triple-negative breast cancer
7/1/18 → 2/28/22
Project: Research project
Triple Negative Breast Neoplasms
Breast Neoplasms
Polycomb Repressive Complex 2
Polycomb-Group Proteins
DNA Repair
The EZH2 and Chromosomal Passenger Complex Network in Prostate Cancer
7/1/18 → 12/31/19
Project: Research project
Prostatic Neoplasms
Aurora Kinases
Polycomb-Group Proteins
Proteins
Neoplasms
A Novel Role for Polycomb Group Proteins in Androgen Signaling and Prostate Cancer
7/1/18 → 5/20/19
Project: Research project
Polycomb-Group Proteins
Androgens
Prostatic Neoplasms
Proteins
Neoplastic Stem Cells
Research Output 2003 2019
1
Citation
(Scopus)
B lymphoma Moloney murine leukemia virus insertion region 1: An oncogenic mediator in prostate cancer
Liu, Q., Li, Q., Zhu, S., Yi, Y. & Cao, Q., May 1 2019, In : Asian Journal of Andrology. 21, 3, p. 224-232 9 p.Research output: Contribution to journal › Review article
Open Access
Moloney murine leukemia virus
Lymphoma
Prostatic Neoplasms
Neoplasms
Epigenomics
BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer
Zhu, S., Zhao, D., Li, C., Li, Q., Jiang, W., Liu, Q., Wang, R., Fazli, L., Li, Y., Zhang, L., Yi, Y., Meng, Q., Wang, W., Wang, G., Zhang, M., Zu, X., Zhao, W., Deng, T., Yu, J., Dong, X. & 2 others, , Jan 1 2019, (Accepted/In press) In : Oncogene.Research output: Contribution to journal › Article
Castration
Androgen Receptors
Lymphoma
Prostatic Neoplasms
Neoplasms
Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression
Vantaku, V., Putluri, V., Bader, D. A., Maity, S., Ma, J., Arnold, J. M., Rajapakshe, K., Donepudi, S. R., von Rundstedt, F. C., Devarakonda, V., Dubrulle, J., Karanam, B., McGuire, S. E., Stossi, F., Jain, A. K., Coarfa, C., Cao, Q., Sikora, A. G., Villanueva, H., Kavuri, S. M. & 3 others, , Jan 1 2019, In : Oncogene.Research output: Contribution to journal › Article
Urinary Bladder Neoplasms
Epigenomics
NADP
Nucleotides
Aldehyde Oxidase
1
Citation
(Scopus)
Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer
Liu, Q., Wang, G., Li, Q., Jiang, W., Kim, J. S., Wang, R., Zhu, S., Wang, X., Yan, L., Yi, Y., Zhang, L., Meng, Q., Li, C., Zhao, D., Qiao, Y., Li, Y., Gursel, D. B., Chinnaiyan, A. M., Chen, K. & Cao, Q., Jul 15 2019, In : International Journal of Cancer. 145, 2, p. 415-426 12 p.Research output: Contribution to journal › Article
Polycomb-Group Proteins
Ectoderm
Androgen Receptors
Embryonic Development
Prostatic Neoplasms
1
Citation
(Scopus)
Roles of the HOXA10 gene during castrate-resistant prostate cancer progression
Long, Z., Li, Y., Gan, Y., Zhao, D., Wang, G., Xie, N., Lovnicki, J. M., Fazli, L., Cao, Q., Chen, K. & Dong, X., Mar 1 2019, In : Endocrine-related cancer. 26, 3, p. 279-292 14 p.Research output: Contribution to journal › Article
Homeobox Genes
antineoplaston A10
Prostatic Neoplasms
Androgen Receptors
Fatty Acid Synthases